FDA warning on vaginal laser procedures should emphasize informed choices, not fear
On July 30th, the FDA sent out a stern warning against the use of energy devices (laser therapy) to perform “vaginal rejuvenation,” and for procedures to treat symptoms related to sexual function, because of worries about adverse events. I agree with the FDA that these devices need more study, clear indications, informed patients, and skilled and ethical physicians to be used safely. However, I have concerns that the FDA, in an overabundance of caution, may limit availability of innovative therapies, which when used correctly may benefit women’s reproductive health. In addition, press coverage is causing confusion about the different procedures. Genitourinary syndrome of menopause (GSM) The North American Menopause Society and International Society for the Study of Women’s Sexual Health recently introduced the term genitourinary syndrome of menopause (GSM) to describe the constellation of signs and symptoms associated with decreased estrogen and other hormones at the time of menopause. This syndrome affects approximately 50% of menopausal women and can cause vaginal dryness, itching, irritation, discharge, and painful sex. Vulvovaginal atrophy often worsens over time when it is not treated, unlike hot flashes that usually go away within a few years. Over 90% of women do not seek treatment for vaginal dryness and painful intercourse because of stigma, embarrassment, or doubt that there are safe therapies to help. Standard treatments for GSM fall short f...
Publication date: Available online 30 May 2020Source: Journal of American Association for Pediatric Ophthalmology and StrabismusAuthor(s): Gamze Dereli Can, Muhammet Furkan Korkmaz, Mehmet Erol Can
Publication date: Available online 30 May 2020Source: European Journal of Obstetrics &Gynecology and Reproductive BiologyAuthor(s): Alessandra Graziottin, Filippo Murina, Dania Gambini, Stefania Taraborrelli, Barbara Gardella, Maria Campo, the VuNet Study Group
Publication date: Available online 30 May 2020Source: BurnsAuthor(s): Gopal Nambi S, Walid Kamal Abdelbasset
Publication date: Available online 30 May 2020Source: EXPLOREAuthor(s): Bihter Akin, Birsen Karaca Saydam
Authors: Infusino F, Cimino S, Lombardi M, Mancone M, Cavarretta E, Frati G, Pugliese F, Fedele F, Biondi-Zoccai G Abstract SARS-CoV-2 is spreading rapidly all over the world. The case fatality rate seems higher in cardiovascular disease and hypertension. Other comorbidities do not seem to confer the same risk, therefore the understanding of the relationship between infection and cardiovascular system could be a crucial point for the fight against the virus. A great interest is currently directed towards the angiotensin 2 converting enzyme (ACE 2) which is the SARS-CoV-2 receptor and creates important connections b...
HIGH blood pressure symptoms can be difficult to spot, but may include severe headaches, chest pain, and finding blood in your urine. You could lower your chances of deadly hypertension symptoms and signs by smelling lavender oil, it's been claimed. Should you check your blood pressure?
Authors: Krajewska-Włodarczyk M, Owczarczyk-Saczonek A, Placek W Abstract Introduction: Fatigue is an important and underrated symptom of many chronic diseases. Aim: The evaluation of incidence and severity of fatigue as well as the influence of selected factors on fatigue in patients with psoriasis and psoriatic arthritis (PsA). Material and methods: The study included 60 patients with PsA, 58 patients with psoriasis and 61 persons in the control group aged 35-70 years. Assessment of fatigue was conducted using a fatigue subscale from the FACIT-F questionnaire. Severity of skin lesions and arthritis was d...
We present a case of cannabinoid hyperemesis syndrome that was diagnosed and treated in a combat-zone US military emergency department in Southwest Asia. PMID: 32472123 [PubMed - as supplied by publisher]
CONCLUSIONS: This unprecedented crisis may interact with certain dimensions of the suicidal process. However, it is time to innovate. Several suicide prevention tools all have their place in new modes of care and should be tested on a large scale. PMID: 32471707 [PubMed - as supplied by publisher]
CONCLUSION: Current literature suggests an important and growing concern for the abuse of PRG. Male sex, psychiatric and/or addiction history, including opioid addiction, may be potential risk factors for the development of addictive behaviours associated with PRG. PMID: 32471706 [PubMed - as supplied by publisher]